Glucotrack (GCTK) Net Cash Flow Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | -63.96% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | -55.30% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 126.35% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | -159.29% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 34.18% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 36.49% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 45.74% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | -124.07% |
| 10 | Glucotrack | 290,858.33 | -7.09 Mn | - | 20.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20.94% |
| Sep 30, 2025 | -40.71% |
| Jun 30, 2025 | 34.89% |
| Mar 31, 2025 | 67.80% |
| Dec 31, 2024 | 94.94% |
| Sep 30, 2024 | 30.63% |
| Jun 30, 2024 | -25.58% |
| Mar 31, 2024 | -47.61% |
| Dec 31, 2023 | -41.50% |
| Sep 30, 2023 | -33.17% |
| Jun 30, 2023 | -1.85% |
| Mar 31, 2023 | -28.25% |
| Dec 31, 2022 | -5.44% |
| Sep 30, 2022 | 17.28% |
| Jun 30, 2022 | -34.12% |
| Mar 31, 2022 | -160.83% |
| Dec 31, 2021 | -5.78% |
| Sep 30, 2021 | -43.85% |
| Jun 30, 2021 | -48.56% |
| Mar 31, 2021 | -76.05% |
| Dec 31, 2020 | -27.42% |
| Sep 30, 2020 | -6.35% |
| Jun 30, 2020 | -18.54% |
| Mar 31, 2020 | 102.23% |
| Sep 30, 2019 | -13.73% |
| Jun 30, 2019 | 19.66% |
| Mar 31, 2019 | 47.15% |
| Sep 30, 2018 | 38.85% |
| Jun 30, 2018 | 38.94% |
| Mar 31, 2018 | 31.09% |
| Sep 30, 2017 | -29.52% |
| Jun 30, 2017 | 19.08% |
| Mar 31, 2017 | 57.34% |
| Sep 30, 2016 | 5.43% |
| Jun 30, 2016 | 48.38% |
| Mar 31, 2016 | -28.09% |
| Sep 30, 2015 | -29.41% |
| Jun 30, 2015 | -26.42% |
| Mar 31, 2015 | -29.54% |
| Sep 30, 2014 | 56.66% |
| Jun 30, 2014 | -68.49% |
| Mar 31, 2014 | -81.50% |
| Dec 31, 2013 | -39.84% |